These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34414957)

  • 21. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
    Wu P; Sun W; Zhang H
    Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.
    Gao W; Li L; Han X; Liu S; Li C; Yu G; Zhang L; Zhang D; Liu C; Meng E; Hong S; Wang D; Guo P; Shi G
    BMC Cancer; 2021 Mar; 21(1):331. PubMed ID: 33789609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
    Wang T; Chen B; Meng T; Liu Z; Wu W
    Bioengineered; 2021 Dec; 12(1):1555-1575. PubMed ID: 33955820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
    Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
    World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma.
    Chen L; Zhou Q; Liu J; Zhang W
    Front Immunol; 2021; 12():759565. PubMed ID: 34777372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
    Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X
    J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
    Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
    Front Oncol; 2021; 11():766072. PubMed ID: 34868990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.